SENSEX    73738.45       89.83    |    NIFTY    22368       31.60 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Sun Pharma in spotlight after launch of generic Welchol tablets in US
18-May-18   07:59 Hrs IST

Sun Pharmaceutical Industries announced that one of its wholly-owned subsidiaries has launched in US, the Authorized Generic (AG) version for Daiichi Sankyo Inc.'s Welchol (colesevelam hydrochloride) 625mg tablets. The launch is pursuant to a distribution and supply agreement between Sun Pharma's wholly owned subsidiary and Daiichi Sankyo Inc., which grants the Sun Pharma subsidiary, exclusive rights to distribute these tablets in the US for a pre-determined period. Welchol Tablets recorded US sales of approximately $520 million for the 12 months ending March 2018, as per IQVIA. The announcement was made after market hours yesterday, 17 May 2018.

Godrej Agrovet announced that its subsidiary, Creamline Dairy Products (CDPL), as a part of its expansion plans, intends to invest Rs 400 crore in 3 greenfield milk processing plants in Tamil Nadu, North Karnataka and Maharashtra over the period of next 3 years. The announcement was made after market hours yesterday, 17 May 2018.

CDPL had recently acquired a processing plant in Tirunelveli, Tamil Nadu and is in the process of setting up another plant in Visakhapatnam. The objectives behind this proposed expansion includes growing the share of value-added milk products. In view of the same, it is expected that the milk processing capacity of CDPL would increase from 12 lakh litres per day to 15 lakh litres per day. Further, CDPL may plan to raise funds through debt or by way of public issue, if required, subject to necessary approvals.

Vijaya Bank announced that a board meeting will be held on 20 May 2018 to discuss on the capital raising plan under BASEL-III for the financial year 2018-2019. The announcement was made after market hours yesterday, 17 May 2018.

Gujarat State Fertilizers & Chemicals (GSFC) said it signed a non-binding memorandum of understanding (MoU) with Centrex Metals, Australia, for the purchase of 3,00,000 tonnes per annum (dry basis) of rock phosphate for 10 years. The said proposal upon its implementation shall be immensely useful to GSFC for the purpose of its backward and forward integration strategies. The announcement was made after market hours yesterday, 17 May 2018.

India Tourism Development Corporation (ITDC) announced that a share transfer agreement has been signed amongst ITDC, Arunachal Pradesh Industrial Development & Financial Corp (APIDFC), Donyi Polo Ashok Hotel Corporation (DPAHCL) and Government of Arunachal Pradesh (GoAP) for transfer of 51% equity stake of ITDC in DPAHCL, the joint venture subsidiary company, to APIDFC/GoAP on a consideration amount of Rs 1.98 crore. The announcement was made after market hours yesterday, 17 May 2018.

On a consolidated basis, Voltas' net profit fell 3.13% to Rs 194.19 crore on 1.15% increase in net sales to Rs 2021.30 crore in Q4 March 2018 over Q4 March 2017. The result was announced after market hours yesterday, 17 May 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.89 1.07
United Kingdom (GBP) 1.16 1.00 103.18 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.42 1.00
Market News << ALL News
  23-Apr-2024, (05:10 )  Tata Consumer Q4 PAT..
  23-Apr-2024, (04:00 )  NBCC rallies as new ..
  23-Apr-2024, (03:27 )  Artson Engineering h..
  23-Apr-2024, (03:25 )  Aarti Drugs Baddi fa..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)